Monitoring Kidney Dysfunction in Kugelberg-Welander Syndrome.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
03 Apr 2019
03 Apr 2019
Historique:
entrez:
4
4
2019
pubmed:
4
4
2019
medline:
4
12
2019
Statut:
epublish
Résumé
BACKGROUND Kugelberg-Welander (K-W) syndrome is a type of spinal muscular atrophy that causes weakness of the hip-girdle muscles. If severe enough, this weakness can confine patients to a wheelchair in adult life. Proteinuria, a manifestation of kidney dysfunction, is associated with disorders of many organ systems. The evaluation of kidney function in the context of K-W syndrome is challenging. CASE REPORT A 45-year-old man with K-W syndrome first diagnosed at 5 years of age developed peripheral edema and was found to have proteinuria under 1 g/24 h. His past history was significant for hypertension for 7 years. He was managed conservatively initially, but over the next year the serum creatinine concentration increased from 18 to 32 µmol/L (0.2 to 0.36 mg/dL). A percutaneous kidney biopsy was performed in the fetal position due to an inability of the patient to lay prone or supine. Minimal change disease (MCD) was diagnosed. Treatment consisted of dietary salt restriction, ramipril, amiloride, and hydrochlorothiazide, while avoiding corticosteroids. The serum creatinine concentration initially returned to the 18-20 µmol/L (0.2-0.22 mg/dL) range with increased fluid intake, but then slowly declined to 6 µmol/L (0.07 mg/dL) over the next 14 years. Muscle strength remained poor. CONCLUSIONS K-W syndrome, when associated with proteinuria, presents novel diagnostic and therapeutic challenges to the latter. The serum creatinine concentration may be unhelpful in assessing kidney function in K-W syndrome. A conservative management approach to MCD is reasonable to minimize comorbidity.
Identifiants
pubmed: 30943186
pii: 914458
doi: 10.12659/AJCR.914458
pmc: PMC6459160
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
441-446Références
Leuk Lymphoma. 2001 Jul;42(3):561-6
pubmed: 11699426
Kidney Int. 2004 Feb;65(2):634-41
pubmed: 14717935
Nephrol Dial Transplant. 2009 May;24(5):1524-8
pubmed: 19074409
Eur J Hum Genet. 2012 Jan;20(1):27-32
pubmed: 21811307
Kidney Int. 2012 Oct;82(8):840-56
pubmed: 22895519
Kidney Int. 2013 Jul;84(1):34-44
pubmed: 23364518
Int J Biochem Cell Biol. 2013 Oct;45(10):2173-8
pubmed: 23838168
Neurol Clin. 2014 Aug;32(3):647-70, viii
pubmed: 25037083
Ann Clin Transl Neurol. 2016 Jun 23;3(7):537-46
pubmed: 27386502
Biochim Biophys Acta Gene Regul Mech. 2017 Mar;1860(3):299-315
pubmed: 28095296
Expert Rev Neurother. 2017 Oct;17(10):955-962
pubmed: 28884620
Neurology. 2018 Apr 24;90(17):e1501-e1509
pubmed: 29572281
J Clin Med. 2018 Aug 31;7(9):null
pubmed: 30200278
Neurology. 2018 Nov 13;91(20):923-933
pubmed: 30315070
Br Med J. 1966 Jun 11;1(5501):1458-61
pubmed: 5933049
J Am Soc Nephrol. 1997 May;8(5):824-32
pubmed: 9176855
Acta Radiol. 1997 May;38(3):431-6
pubmed: 9191436